The American Society of Clinical Oncology (ASCO) has grave concerns about the Trump Administration’s executive order calling in part for federal rules to encourage association health plans. The means to achieve ASCO’s core mission requires that patients with cancer have meaningful access to high-quality care.
The Trump administration’s move to expand the rights of employers to opt out of the requirement for contraceptive coverage would have unexpected and deleterious consequences for patients of child-bearing age with cancer. Women of child-bearing age with cancer and their male partners are advised as a part of standard oncology care to practice contraception—considered as a preventive service under the Affordable Care Act—to reduce the chances of miscarriages and birth defects.
The American Society of Clinical Oncology (ASCO) and Friends of Cancer Research (Friends) are calling for the use of more inclusive eligibility criteria for cancer clinical trials. This recommendation is in conjunction with the release of a Special Series, published today in the Journal of Clinical Oncology (JCO). The series, which includes a joint ASCO-Friends research statement, provides a comprehensive examination of eligibility criteria for cancer clinical trials with recommendations to address eligibility criteria in five specific areas: minimum age requirements for trial enrollment, HIV/AIDS status, brain metastases, organ dysfunction, and prior and concurrent malignancies.
The American Society of Clinical Oncology (ASCO) today presented Representative Leonard Lance (NJ-7) with its second annual Congressional Leadership Award in recognition of the lawmaker's exceptional commitment to supporting cancer research and treatment. The ASCO award honors a member of Congress who is a leading champion for patients and survivors of cancer, their families, and their cancer care teams.
ALEXANDRIA, Va. – New research examining patient-physician communication, yoga as supportive care, and psychosocial support for people with cancer will be featured in the official Press Program for the 2017 Palliative and Supportive Care in Oncology Symposium. Co-sponsors announced today the four abstracts that will be included in the Press Program.
ALEXANDRIA, Va. -- CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO®), has announced that Southeastern Medical Oncology Center (SMOC) recently signed an agreement to participate in the CancerLinQ® platform, the first oncology practice in Eastern North Carolina to do so.
ALEXANDRIA, Va. - Effective clinician communication is a core element of all patient-centered oncology care. The complexities of cancer, and its ever-present association with mortality, require specialized communication skills.
ALEXANDRIA, Va. – The American Society of Clinical Oncology, Inc. (ASCO®) has announced that the first three practices in Spain have received Quality Oncology Practice Initiative (QOPI®) certification through QOPI Certification Program™, LLC (QCP). The accreditations were given today at the European Society of Medical Oncology (ESMO) 2017 Congress in Madrid, Spain.
Philadelphia, September 7, 2017 – The American College of Cardiology (ACC), American College of Physicians (ACP) and American Society of Clinical Oncology (ASCO) have committed to working with the American Board of Internal Medicine (ABIM) to explore development of collaborative pathways through which physicians can maintain board certification.
ALEXANDRIA, Va. -- CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO®), has announced that West Cancer Center in Tennessee has signed an agreement to participate in the CancerLinQ® platform.
The rate of human papilloma virus (HPV) vaccination in the United States is increasing, but remains lower than ideal. A new study suggests that survivors of childhood cancer receive the HPV vaccine at an even lower rate than their peers without cancer ̶ 24% versus 40%. Nearly three quarters of study participants reported that their healthcare provider did not proactively recommend vaccination.
A new population-based study shows that palliative care substantially decreased healthcare utilization among Medicare beneficiaries with advanced cancer, resulting in less intensive care being delivered at the end of life. This included lower rates of hospitalization, fewer invasive procedures, and reduced chemotherapy administration at the end of life, along with higher rates of hospice enrollment and stays. This study was published today in the Journal of Oncology Practice (JOP).
ALEXANDRIA, Va. - An update of the American Society of Clinical Oncology (ASCO) clinical practice guideline clarifies the role of immunotherapy in the treatment of patients with advanced non-small-cell lung cancer (NSCLC). The update also provides new recommendations on the use of targeted therapies for patients with changes in tumor EGFR, ALK, and ROS1 genes.
Researchers found that the survival rate of patients with advanced cancer who have cardiac arrest in a hospital setting is about half that of patients without advanced cancer. Although patients in the study with advanced cancer more frequently had “do not resuscitate” orders after their cardiac arrest than those without advanced cancer (55.6% versus 43%), this does not fully explain the survival differences. This new study was published today in the Journal of Oncology Practice (JOP).
ALEXANDRIA, Va. - An update of the American Society of Clinical Oncology (ASCO) clinical practice guideline covers new medicines for nausea and vomiting related to cancer treatment. The update, issued today, provides new evidence-based information on the appropriate use of olanzapine, NK1 receptor antagonists and dexamethasone.